Form 4 • Statement of Changes in Beneficial Ownership
Type
Sell
Net shares
+877
% of shares
0.86%
Amount (USD)
$4,352
Insider confidence score
67.5 out of 100
Positive
Negative
Security
Common Stock
Action
Grant
Date
2026-03-02
Code
A
Net shares
+499.0
Price per Share
$35.97
Amount (USD)
$17,949.03
Acquired/Disposed
Acquired
Shares Owned Before
78,626.0
Shares Owned After
79,125.0
Security
Common Stock
Action
Grant
Date
2026-03-02
Code
A
Net shares
+499.0
Acquired/Disposed
Acquired
Shares Owned Before
79,125.0
Shares Owned After
79,624.0
Security
Common Stock
Action
Tax_withhold
Date
2026-03-03
Code
F
Net shares
-121.0
Price per Share
$35.97
Amount (USD)
$4,352.37
Acquired/Disposed
Disposed
Shares Owned Before
79,624.0
Shares Owned After
79,503.0
1. The Reporting Person purchased shares ("Purchase Plan Shares") of the Issuer's common stock pursuant to a purchase plan ("Purchase Plan") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on March 2, 2026.
2. In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase.
3. Includes 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025, 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025 and 224 share underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
4. Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary.
5. These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
6. The closing price on March 2, 2026 was used to calculate the withholding obligation.
7. Includes 997 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 2, 2025, and 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025 and 224 share underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
8. These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
9. These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.